To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Karen Stein
Eisai Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Birmingham Hematology and Oncology Associates
Birmingham, Alabama, United States
- Stanford University Cancer Center
Stanford, California, United States
- Stockton Hematology Oncology
Stockton, California, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Pasco Pinellas Cancer Center
New Port Richey, Florida, United States
- Gulf Coast Oncology
St. Petersburg, Florida, United States
- University of Chicago
Chicago, Illinois, United States
- Siouxland Haeatology - Oncology Associates
Sioux City, Iowa, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- Sletten Cancer Institute
Great Falls, Montana, United States
- Cornell Medical Center
New York, New York, United States
- Carolinas Medical Center Northeast Northeast Oncology Associates
Concord, North Carolina, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- Oncology and Hematology Care
Cincinnati, Ohio, United States
- University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
- Charleston Hematology Oncology Associates
Charleston, South Carolina, United States
- Sarah Cannon Cancer Center
Nashville, Tennessee, United States
- Utah Cancer Specialists
Salt Lake City, Utah, United States
- Gunderson Clinic Ltd.
La Crosse, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2009
- Primary completion
- 31 Jan 2011
- Completion
- —
- Last update posted
- 29 Oct 2014
- Registered enrollment
- 26
- Registry id
- NCT01011283
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.